1. Postma MJ, Staginnus U, Ruitenberg EJ. Pharmaco-economics of blood transfusion safety measures: a review of the literature. Value Health. 2001;6:476.
2. Van Hulst M, de Wolf JTM, Staginnus U, Ruitenberg EJ, Postma MJ. Pharmaco-economics of blood transfusion safety; review of the available evidence. Vox Sang. 2002;83:146–55.
3. United States Food and Drug Administration. Bacterial risk control strategies for blood collection establishments and transfusion services to enhance the safety and availability of platelets for transfusion: guidance for industry. 2019. https://www.fda.gov/media/123448/download. Accessed 5 Sept 2020.
4. United States Food and Drug Administration. Bacterial risk control strategies for blood collection establishments and transfusion services to enhance the safety and availability of platelets for transfusion: draft guidance for industry. 2018. https://www.fda.gov/media/119043/download. Accessed 5 Sept 2020.
5. United States Food and Drug Administration. Revised recommendations for reducing the risk of Zika Virus transmission by blood and blood components: guidance for industry. 2018. https://www.fda.gov/media/99797/download. Accessed 5 Sept 2020.